Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Calle Sant Ferrán 74
City: Cornellá de Llobregat
State: barcelona
Zip: 08940
Country: ES
Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.
Contact Phone:
Contact Email:
Listed Exchange:
BME Spanish Exchanges
IPO Date:
12/15/2015
Ticker Symbol:
ORY
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
3/2009 | Crystax Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|